News Medical on MSN7d
Alzheimer’s and Parkinson’s linked to aging brain’s failing waste disposal
New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
biopharma-reporter7d
Inhibikase to pause development of Parkinson’s drug
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...
Hosted on MSN11d
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthrough
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
ScienceAlert18d
Parkinson's Discovery Suggests We Could Already Have an FDA-Approved Treatment
Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...
Yahoo18d
Parkinson's Discovery Suggests We Could Already Have an FDA-Approved Treatment
Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for Parkinson's disease from cell-to-cell in the brain. In a paper published ...
GlobalData on MSN11h
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
pharmaphorum2d
Roche's Parkinson's hope fails second clinical trial
"We will continue our close collaboration with the Parkinson's community as we further evaluate the data to determine next steps." Alpha-synuclein is a protein that tends to get misfolded and ...
Knowridge13d
Research shows big cause of Parkinson’s disease and memory disorders
Over time, the disease can also affect memory and lead to dementia. A similar condition called Lewy Body Dementia (LBD), ...
pharmaphorum4d
Sanofi places $75m bet with ABL on popular Parkinson's drug target
Other companies with active alpha-synuclein programmes include AstraZeneca and Takeda with antibody MEDI 1342 in phase 2 for Parkinson's, AC Immune and its vaccine candidate ACI-7104, and small ...